MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-22-0012738
Novel Tissues Private Limited - manufacturing in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹72.03 Cr
▲ 32% YoY
Net profit · FY 2023
₹5.97 Cr
Net margin 8.3%
EBITDA · FY 2023
₹10.82 Cr
EBITDA margin 15%
Authorised capital
₹24 Lakh
Registered with MCA
Paid-up capital
₹24 Lakh
Issued & subscribed
Open charges
₹32.05 Cr
Secured borrowings
Company age
23 yrs
Est. 2003
Employees · EPFO
3
Provident fund records
About Novel Tissues Private Limited
Data last updated:
Novel Tissues Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the paper and packaging products segment of the manufacturing sector. It was incorporated on 30 July 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U05190KA2003PTC032338. Its GSTIN is 29AABCN7652F1ZA (Karnataka). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹24 Lakh and a paid-up capital of ₹24 Lakh. It is led by directors Adaviappa Balappa Doddamani and Lava Basaningappa Doddamani.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at No.2 First Floor City Point13/7 Infantry Road, Bangalore, Karnataka, India – 570018.
As per the financials filed for FY 2023, the company reported a revenue of ₹72.03 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹5.97 Cr (net margin 8.3%) and EBITDA of ₹10.82 Cr (EBITDA margin 15%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 49% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Novel Tissues. As per MCA filings, the company has open charges of ₹32.05 Cr on record. Court records list 6 cases involving the company, including 6 filed against it; 1 case is pending. The company has 14 deals on record (12 secondary share transfers, 2 funding rounds), with disclosed funding of ₹32.5 Lakh; the latest was in March 2022.
Novel Tissues Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-22-0012738). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website noveltissues.com.
Company details
CIN U05190KA2003PTC032338
Registration Number 032338
Incorporation Date 30 July 2003
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-22-0012738
Recognitions & Rankings of Novel Tissues
Contact details
Novel Tissues Private Limited's registered office is in Bangalore, Karnataka. Its website is noveltissues.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.2 First Floor City Point13/7 Infantry Road, Bangalore, Karnataka, India – 570018
- IndustryManufacturing, Paper & Packaging Products
To see the full contact details of Novel Tissues Private Limited, buy the company report.
Comprehensive company report
Novel Tissues Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Novel Tissues operates one associated brand: Novel Tissues. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality tissues and wet wipes for everyday use. | noveltissues.com |
Business activity
The main business activity of Novel Tissues is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Novel Tissues Private Limited, buy the company report.
Financials of Novel Tissues Private Limited
FY 2023 filings availableNovel Tissues Private Limited reported revenue of ₹72.03 Cr (up 32% YoY) for FY 2023.
Revenue · FY 2023
₹72.03 Cr ▲ 32%
Net profit · FY 2023
₹5.97 Cr margin 8.3%
EBITDA · FY 2023
₹10.82 Cr margin 15%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 52%
5 years · compounded
▲ 49%
EBITDA CAGR growth
1 year
▲ 45%
3 years · compounded
▲ 34%
5 years · compounded
▲ 35%
Revenue has grown at a compounded annual rate (CAGR) of 49% over five years, including 32% growth in the latest year. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹72.03 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.82 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.97 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15% | ||||
| Net Profit Margin | 8.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novel Tissues Private Limited, buy the company report.
Board of directors of Novel Tissues Private Limited
Novel Tissues has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Adaviappa Balappa Doddamani | Director | 08 Sep 2011 | 15 Years 1 Months | Current |
| Lava Basaningappa Doddamani | Director | 11 Nov 2013 | 12 Years 11 Months | Current |
Auditor
Novel Tissues Private Limited is audited by MOHANA MANI AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MOHANA MANI AND ASSOCIATES | FY 2023 | 010711S |
Shareholding
The shareholding of Novel Tissues Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Novel Tissues Private Limited, buy the company report.
Charges & borrowings
Open charges
₹32.05 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Mar 2025 | 101077732 | Sidbi | ₹2 Cr | Open | |
| 28 Jun 2024 | 100951228 | Sidbi | ₹5.95 Cr | Open | |
| 28 Jun 2024 | 100951097 | Sidbi | ₹2 Cr | Open | |
| 21 Mar 2023 | 100749385 | Canara Bank | ₹60 Lakh | Open | |
| 16 Jun 2022 | 100581424 | Sidbi | ₹6.95 Cr | Open |
To see the full charge records of Novel Tissues Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Novel Tissues Private Limited has 14 deals on record (12 secondary share transfers, 2 funding rounds), with disclosed funding of ₹32.5 Lakh; the latest was in March 2022.
Total deals
14
Secondary share transfers
12
Funding rounds
2
Disclosed funding
₹32.5 Lakh
Deals on record (5 of 14)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Shree Mallikarjuna Sugars Limited , an individual |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Shree Mallikarjuna Sugars Limited |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Shree Mallikarjuna Sugars Limited |
| Sep 2011 | Secondary share transfer | Undisclosed | Buyer: Shree Mallikarjuna Sugars Limited Seller: an individual |
To see the full deal history of Novel Tissues Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Novel Tissues Private Limited has 6 court cases on record: 6 filed against it. 1 case is pending and 5 are disposed.
Total cases
6
Filed against the company
6
Pending
1
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
| High courts | 2 | 2 | 1 |
Cases on record (4 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Court case (MFA) | Filed against the company | Pending |
| High Court | Court case ((T)OP(TM)) | Filed against the company by Shreeja Menon Trading As M/S.Shwethas Hygeine Products | Disposed |
| District court, MYSURU, Karnataka | Motor accident claim | Filed against the company | Disposed |
| District court, MYSURU, Karnataka | Motor accident claim | Filed against the company | Disposed |
To see the full case history of Novel Tissues Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novel Tissues Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Novel Tissues Private Limited has a workforce of 3 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
3
Active EPFO establishments
1
Employee growth
50%
GST
Novel Tissues has 4 GST registrations: 4 active.
Total GSTINs
4
Active
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCN7652F1ZA | Karnataka | Active | 01 Jul 2017 |
| 27AABCN7652F1ZE | Maharashtra | Active | 17 Jul 2021 |
| 06AABCN7652F1ZI | Haryana | Active | 01 Jun 2022 |
| 34AABCN7652F1ZJ | Puducherry | Active | 09 Jan 2024 |
To see the full GST registrations and return filing status of Novel Tissues Private Limited, buy the company report.
Recent activity
Novel Tissues Private Limited has 11 board changes on record since 2008: 2 appointments and 9 cessations. The latest: Lava Basaningappa Doddamani was appointed as Director on 11 Nov 2013.
Charges
A charge with Sidbi amounted to Rs. 200.00 Lakh with Charge ID 101077732 was registered on 19 Mar 2025.
Charges
A charge with Sidbi amounted to Rs. 595.00 Lakh with Charge ID 100951228 was registered on 28 Jun 2024.
Charges
A charge with Sidbi amounted to Rs. 200.00 Lakh with Charge ID 100951097 was registered on 28 Jun 2024.
AGM
Novel Tissues Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Novel Tissues Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Charges
A charge with Canara Bank amounted to Rs. 60.00 Lakh with Charge ID 100749385 was registered on 21 Mar 2023.
Charges
A charge with Sidbi amounted to Rs. 695.00 Lakh with Charge ID 100581424 was registered on 16 Jun 2022.
Charges
A charge with Sidbi of Rs. 635.00 Lakh registered on 29 Mar 2022 with Charge ID 100552537 was modified on 11 May 2022.
Charges
A charge with Sidbi amounted to Rs. 635.00 Lakh with Charge ID 100552537 was registered on 29 Mar 2022.
Charges
A charge with Canara Bank of Rs. 375.10 Lakh registered on 04 Feb 2004 with Charge ID 90196470 was modified on 30 Nov 2021.
Charges
A charge with Sidbi amounted to Rs. 270.00 Lakh with Charge ID 100344019 was registered on 24 Jun 2020.
Charges
A charge with Sidbi amounted to Rs. 50.00 Lakh with Charge ID 100341607 was registered on 08 May 2020.
17 earlier events are in the company report.
Frequently asked questions
Novel Tissues is an active private limited company based in Bangalore, Karnataka, India. The company works in paper and packaging products, within the manufacturing industry. It was incorporated on 30 July 2003 (23+ years old) and is registered under CIN U05190KA2003PTC032338.
Novel Tissues has 2 current directors:
- Adaviappa Balappa Doddamani - Director
- Lava Basaningappa Doddamani - Director
The latest financial statements of Novel Tissues on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Novel Tissues is 29AABCN7652F1ZA, registered in Karnataka. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 27AABCN7652F1ZE (Maharashtra), 06AABCN7652F1ZI (Haryana), 34AABCN7652F1ZJ (Puducherry).
The CIN (Corporate Identification Number) of Novel Tissues is U05190KA2003PTC032338. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novel Tissues has 6 court cases on record: 6 filed against it. 1 is pending. Most are in the district courts.
Novel Tissues was incorporated on 30 July 2003, making it 23+ years old. It is registered with the Registrar of Companies, Bangalore.
Novel Tissues has 14 deals on record (12 secondary share transfers, 2 funding rounds), with disclosed funding of ₹32.5 Lakh; the latest was in March 2022.
Lava Basaningappa Doddamani was appointed as Director on 11 Nov 2013. Mallikarjuna Balappa ceased to be Director on 11 Nov 2013. Emmanuel Varkey Chempottickal ceased to be Director on 25 Sep 2013. Novel Tissues has 11 board changes on record in total.
Yes, Novel Tissues is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-22-0012738).